Didanosine-ribavirin combination:: synergistic combination in vitro, but high potential risk of toxicity in vivo

被引：4

作者：

Bruno, R ^{[1
]}

Sacchi, P ^{[1
]}

Filice, G ^{[1
]}

机构：

[1] Univ Pavia, Policlin San Matteo, IRCCS, Div Malattie Infett & Trop, I-27100 Pavia, Italy

来源：

AIDS | 2003年 / 17卷 / 18期

关键词：

D O I：

10.1097/01.aids.0000096864.36052.16

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

收藏

页码：2676 / I

页数：2

相关论文

共 6 条

[1] Assessment of mitochondrial toxicity in human cells treated with tenofovir: Comparison with other nucleoside reverse transcriptase inhibitors
Birkus, G
Hitchcock, MJM
Cihlar, T
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (03) : 716 - 723
[2] Mitochondrial toxicity in HIV-HCV coinfection: It depends on the choice of antiretroviral drugs?
Bruno, R
Sacchi, P
Filice, G
[J]. HEPATOLOGY, 2002, 35 (02) : 500 - 501
[3] Hor R, 2002, HEPATOLOGY, V36, p283A
[4] Didanosine, interferon-alfa and ribavirin: a highly synergistic combination with potential activity against HIV-1 and hepatitis C virus
Klein, MB
Campeol, N
Lalonde, RG
Brenner, B
Wainberg, MA
[J]. AIDS, 2003, 17 (07) : 1001 - 1008
[5] Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection
Lafeuillade, A
Hittinger, G
Chadapaud, S
[J]. LANCET, 2001, 357 (9252) : 280 - 281
[6] Interferon and ribavirin combination therapy for chronic hepatitis C in human immunodeficiency virus-infected patients with congenital coagulation disorders
Sauleda, S
Juárez, A
Esteban, JI
Altisent, C
Ruiz, I
Puig, L
Esteban, R
Guardia, J
[J]. HEPATOLOGY, 2001, 34 (05) : 1035 - 1040